DOCTORS HOSPITAL AT RENAISSANCE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 241
- Companies
- 40
- Average per transaction
- $5,119
Who reported the payments
| Intuitive Surgical | $424,951 |
| Genentech, Inc. | $185,472 |
| Stryker | $161,820 |
| Novartis | $110,425 |
| Medartis Inc. | $57,351 |
| Bayer | $49,224 |
| Olympus America Inc. | $48,824 |
| Johnson & Johnson | $31,413 |
| Amgen | $20,300 |
| Kowa Research Institute, Inc. | $19,825 |
| AstraZeneca | $16,107 |
| Neurocrine Biosciences, Inc. | $13,500 |
| Lunit Americas, Inc. | $10,333 |
| AbbVie | $9,500 |
| Pfizer | $6,000 |
| Biotronik Inc. | $4,539 |
| Novo Nordisk | $4,500 |
| Novo Nordisk AS | $4,268 |
| Otsuka America Pharmaceutical, Inc. | $4,000 |
| Abbott | $3,937 |
| Roche Diagnostics Corporation | $3,333 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | $3,000 |
| Insulet Corporation | $3,000 |
| Alkermes, Inc. | $3,000 |
| CSL Behring | $3,000 |
| Boston Scientific | $2,957 |
| Shockwave Medical, Inc | $2,732 |
| E.r. Squibb & Sons, L.L.C. | $2,500 |
| Biogen | $2,500 |
| Eisai Inc. | $2,000 |
| Sanofi US Services Inc. | $1,899 |
| Sanofi-aventis U.S. LLC | $1,500 |
| Teva Pharmaceuticals USA, Inc. | $1,500 |
| Regeneron Healthcare Solutions, Inc. | $1,500 |
| GE HealthCare | $1,252 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,000 |
| Argenx US, Inc. | $1,000 |
| Penumbra, Inc. | $1,000 |
| ANI Pharmaceuticals, Inc. | $1,000 |
| Sanofi | $1,000 |